secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2026-07-15T21:18:59+00:00
Accession:  0001193125-26-304964
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio prices $18.25/share offering of 6M shares and pre-funded warrants; net proceeds ~$187.6M
--------------------------------------------------------------------------------

- Offering of 6,027,399 shares at $18.25 and pre-funded warrants for 4,931,506 shares at $18.2499.
- Net proceeds estimated at $187.6M (or $215.8M if underwriters' option exercised in full).
- Proceeds for working capital, research, clinical development, and commercialization of bempikibart.
- Underwriters: Morgan Stanley, Jefferies, Cantor Fitzgerald, Oppenheimer; close expected July 16, 2026.
- Pre-funded warrants exercisable at $0.0001/share, subject to ownership limits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526304964/0001193125-26-304964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526304964/d150730d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-304964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer